The Journal of Organic Chemistry
Note
= 6.7 Hz, 2H), 7.56 (m, J = 7.2 Hz, 3H), 4.33 (t, J = 6.9 Hz, 2H), 2.40
(t, J = 6.9 Hz, 2H), 2.10 (m, J = 6.9 Hz, 2H); 13C{1H} NMR (100
MHz, DMSO-d6) δ 156.8, 148.6, 143.0, 137.8, 135.9, 131.7, 130.7,
130.0, 129.4 (2C), 128.5, 128.0 (2C), 125.1, 124.1, 122.5, 120.3,
119.4, 48.0, 47.8, 26.7; IR (KBr, cm−1) 3113 (m), 1590 (m), 1497
(w), 1358 (w), 1210 (m), 1108 (w), 1027 (s), 977 (m),775 (w), 522
(m); HRMS (ESI) m/z [M]+ calcd for C21H20N3O3S+ 394.1220,
found 394.1294; [M]− calcd for HSO4− 96.9601, found 96.9649; [M
− H]− calcd for C21H21N3O7S2 490.0748, found 490.0877.
the general procedure: white powder (265 mg, 90%); mp 223−224
°C;40a 1H NMR (400 MHz, DMSO-d6) δ 9.28 (s, 1H), 7.71 (s, 1H),
7.41−7.24 (m, 4H), 5.63 (d, J = 2.7 Hz, 1H), 3.86 (q, J = 7.1 Hz,
2H), 2.30 (s, 3H), 0.97 (t, J = 7.1 Hz, 3H); 13C{1H} NMR (100
MHz, DMSO-d6) δ 165.4, 151.7, 149.8, 142.2, 132.1, 129.8, 129.5,
129.2, 128.2, 98.4, 59.5, 51.9, 18.1, 14.4; HRMS (ESI) m/z [M + H]+
calcd for C14H15ClN2O3 295.0844, found 295.0842.
5-(Ethoxycarbonyl)-6-methyl-4-(4-chlorophenyl)-3,4-dihydro-
pyrimidin-2(1H)-one (4c). The compound was prepared according to
the general procedure: white powder (271 mg, 92%); mp 217−218
°C;40a 1H NMR (400 MHz, DMSO-d6) δ 9.26 (s, 1H), 7.78 (s, 1H),
7.39 (d, J = 8.5 Hz, 2H), 7.24 (d, J = 8.5 Hz, 2H), 5.15 (d, J = 3.2 Hz,
1H), 3.98 (q, J = 7.1 Hz, 2H), 2.26 (s, 3H), 1.09 (t, J = 7.1 Hz, 3H);
13C{1H} NMR (100 MHz, DMSO-d6) δ 165.7, 152.4, 149.2, 144.3,
132.2, 128.9, 128.6, 99.3, 59.7, 53.9, 18.3, 14.5; HRMS (ESI) m/z [M
+ H]+ calcd for C14H15ClN2O3 295.0844, found 295.0848.
5-(Ethoxycarbonyl)-6-methyl-4-(4-nitrophenyl)-3,4-dihydr-opyri-
midin-2(1H)-one (4d). The compound was prepared according to the
general procedure: yellow powder (287 mg, 94%); mp 201−202
°C;40a 1H NMR (400 MHz, DMSO-d6) δ 9.38 (s, 1H), 8.22 (d, J =
8.7 Hz, 2H), 7.91 (s, 1H), 7.51 (d, J = 8.7 Hz, 2H), 5.29 (d, J = 3.3
Hz, 1H), 3.99 (q, J = 7.1 Hz, 2H), 2.28 (s, 3H), 1.10 (t, J = 7.1 Hz,
3H); 13C{1H} NMR (100 MHz, DMSO-d6) δ 165.5, 152.5, 152.2,
149.9, 147.2, 128.1, 124.3, 98.6, 59.9, 54.1, 18.3, 14.5; HRMS (ESI)
m/z [M + H]+ calcd for C14H15N3O5 306.1084, found 306.1082.
5-(Ethoxycarbonyl)-6-methyl-4-(4-methylphenyl)-3,4-dihydro-
pyrimidin-2(1H)-one (4e). The compound was prepared according to
the general procedure: white powder (255 mg, 93%); mp 216−217
°C;40a 1H NMR (400 MHz, DMSO-d6) δ 9.15 (s, 1H), 7.68 (s, 1H),
7.11 (s, 4H), 5.10 (d, J = 3.2 Hz, 1H), 3.98 (q, J = 7.1 Hz, 2H), 2.26
(s, 3H), 2.23 (s, 3H), 1.10 (t, J = 7.1 Hz, 3H); 13C{1H} NMR (100
MHz, DMSO-d6) δ 165.8, 152.6, 148.6, 142.4, 136.8, 129.3, 126.6,
99.9, 59.6, 54.5, 21.1, 18.2, 14.6; HRMS (ESI) m/z [M + H]+ calcd
for C15H18N2O3 275.1390, found 275.1391.
5-(Ethoxycarbonyl)-6-methyl-4-(2-methoxyphenyl)-3,4-dihydro-
pyrimidin-2(1H)-one (4f). The compound was prepared according to
the general procedure: white powder (262 mg, 90%); mp 264−268
°C;40b 1H NMR (400 MHz, DMSO-d6) δ 9.11 (s, 1H), 7.27 (s, 1H),
6.85−7.25 (m, 4H,), 5.49 (d, J = 3.1 Hz, 1H), 3.91 (q, J = 7.1 Hz,
2H), 3.79 (s, 3H), 2.28 (s, 3H), 1.00 (t, J = 7.1 Hz, 3H); 13C{1H}
NMR (100 MHz, DMSO-d6) δ 165.8, 157.0, 152.6, 149.3, 132.1,
129.6, 127.6, 120.6, 111.6, 59.4, 55.8, 49.7, 18.2, 14.5; HRMS (ESI)
m/z [M + H]+ calcd for C15H18N2O4 291.1339, found 291.1336.
5-(Ethoxycarbonyl)-6-methyl-4-(4-methoxyphenyl)-3,4-dihydro-
pyrimidin-2(1H)-one (4g). The compound was prepared according to
the general procedure: white powder (279 mg, 96%); mp 204−206
°C;40a 1H NMR (400 MHz, DMSO-d6) δ 9.15 (s, 1H), 7.70 (s, 1H),
7.13 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 5.09 (d, J = 3.1 Hz,
1H), 3.97 (q, J = 7.1 Hz, 2H), 3.72 (s, 3H), 2.24 (s, 3H),1.10 (t, J =
7.1 Hz, 3H); 13C{1H} NMR (100 MHz, DMSO-d6) δ 165.8, 158.9,
152.6, 148.5, 137.5, 127.9, 114.2, 100.0, 59.6, 55.5, 53.8, 18.2, 14.6;
HRMS (ESI) m/z [M + H]+ calcd for C15H18N2O4 291.1339, found
291.1335.
5-(Ethoxycarbonyl)-6-methyl-4-(4-hydroxyphenyl)-3,4-dihydro-
pyrimidin-2(1H)-one (4h). The compound was prepared according to
the general procedure: white powder (255 mg, 92%); mp 225−226
°C;40c 1H NMR (400 MHz, DMSO-d6) δ 9.32 (s, 1H), 9.10 (s, 1H),
7.57 (s, 1H), 7.01(d, J = 8.1 Hz, 2H), 6.67 (d, J = 8.1 Hz, 2H), 5.03
(d, J = 3.0 Hz, 1H), 3.98 (q, J = 7.1 Hz, 2H), 2.23 (s, 3H), 1.10 (t, J =
7.1 Hz, 3H); 13C{1H} NMR (100 MHz, DMSO-d6) δ 166.3, 157.0,
152.6, 148.6, 136.3, 128.4, 115.4, 100.7, 59.6, 53.4, 18.9, 15.1; HRMS
(ESI) m/z [M + H]+ calcd for C14H16N2O4 277.1183, found
277.1187.
5-(Ethoxycarbonyl)-6-methyl-4-(3-pyridine)-3,4-dihydropy-rimi-
din-2(1H)-one (4i). The compound was prepared according to the
general procedure: white powder (196 mg, 75%); mp 205−206
°C;40d 1H NMR (400 MHz, DMSO-d6) δ 9.31 (s, 1H), 8.45 (d, J =
8.7 Hz, 2H), 7.80 (d, J = 8.7 Hz, 1H), 7.60 (s, 1H), 7.36 (t, J = 8.7
Hz, 1H), 5.20 (d, J = 3.1 Hz, 1H), 3.97 (q, J = 7.1 Hz, 2H), 2.27 (s,
3H), 1.10 (t, J = 7.1 Hz, 3H); 13C{1H} NMR (100 MHz, DMSO-d6)
Synthesis COF-IM and COF-IM-SO3H. Synthesis of COF-IM.
The synthetic procedure refers to our reported work with
modification.10b In brief, a mixture of 1,3,5-tri(4-aminophenyl)-
benzene (TAPB) (56.2 mg, 0.16 mmol), 2,5-dimethoxy terephtha-
laldehyde (DMTPA) (46.5 mg, 0.24 mmol), 1-vinylimidazole (VIM)
(226.4 μL, 2.50 mmol), Yb(OTf)3 (15.0 mg, 0.024 mmol), and DDQ
(8 mg, 0.03 mmol) in 3 mL of MeCN was sealed in a Pyrex tube. The
tube was flash frozen in a liquid nitrogen bath, evacuated to an
internal pressure of 0.5 mbar, and flame-sealed. Upon warming to
room temperature, it was heated under N2 at 80 °C (oil bath) for 3
days. The obtained solids were completely washed with THF (15 mL
× 6) and dried in a vacuum at 120 °C for 24 h to produce COF-IM as
brick red solids in 87% yield (120.3 mg). Elemental Analysis (%)
calcd for (C18H13N3O)n (desolvated) (%): C, 75.22; H, 4.56; N,
14.63; O, 5.57. Found (%): C, 75.45; H, 4.52; N, 14.59; O, 5.35. FT-
IR (KBr, cm−1): 3359 (w), 1592 (m), 1500 (s), 1408 (m), 1288 (w),
1210 (m), 1035 (w), 828 (m). Solid-state 13C {1H} MAS NMR (δ,
ppm): 157, 150, 144, 137, 132, 124, 120, 116, 110, 56.
Synthesis of COF-IM-SO3H. COF-IM (287 mg, 1 mmol) was
dispersed in 20 mL of acetone solution of 1,3-propane sultone (1.1
mmol, 134 mg). After the mixture was stirred at room temperature for
24 h, the precipitate was collected by centrifugation and completely
washed with acetone (5 mL). After drying under a vacuum, the solids
were mixed with 10 mL of H2SO4 aqueous solution (0.05 mM, pH =
4), and the mixture was stirred for 1 h at room temperature to afford
COF-IM-SO3H as brick red solids. According to the elemental
analysis of sulfur content (3.75 wt %), the postsynthetic modification
yield was ca. 48% (197.2 mg). FT-IR (KBr, cm−1): 3359 (w), 1592
(m), 1500 (s), 1408 (w), 1288 (w), 1210 (m), 1108 (w), 1035 (m),
824 (m). Solid-state 13C {1H} MAS NMR (δ, ppm): 157, 150, 142,
137, 134, 124, 120, 117, 112, 56, 50, 23.
Catalytic Biginelli Reaction over COF-IM-SO3H. General
Procedure. In a typical procedure, a mixture of aromatic aldehyde
(1.0 mmol), ethyl acetoacetate (1.0 mmol), and urea (1.0 mmol) was
stirred at 90 °C (oil bath), utilizing COF-IM-SO3H (8.64 mg, 1.0 mol
%) under solvent-free conditions for the appropriate time until the
reaction was complete (monitored by TLC). After the addition of hot
ethanol (5 mL, 60 °C) and after the mixture was centrifuged and
filtrated, the formed precipitate was collected. The crude product was
purified by recrystallization in ethanol, and the structure of the desired
Biginelli adduct (3,4-dihydopyrimidin-2(1H)-ones) was confirmed by
1H NMR, 13C NMR, and MS spectra.
5-Ethoxycarbonyl-6-methyl-4-phenyl-3,4-dihydropyrimidin-
(1H)-one (4a). The compound was prepared according to the general
procedure: white powder (255 mg, 98%); mp 202−204 °C;40a 1H
NMR (400 MHz, DMSO-d6) δ 9.19 (s, 1H), 7.74 (s, 1H), 7.32 (t,
2H), 7.25 (d, 3H), 5.15 (d, J = 3.2 Hz, 1H), 3.97 (q, J = 7.1 Hz, 2H),
2.25 (s, 3H), 1.09 (t, J = 7.1 Hz, 3H); 13C{1H} NMR (100 MHz,
DMSO-d6) δ 165.8, 152.6, 148.8, 145.3, 129.2, 127.7, 126.7, 99.7,
59.6, 54.4, 18.2, 14.5; HRMS (ESI) m/z [M + H]+ calcd for
C14H16N2O3 261.1234, found 261.1234.
5-(Ethoxycarbonyl)-6-methyl-4-(2-chlorophenyl)-3,4-dihy-dro-
pyrimidin-2(1H)-one (4b). The compound was prepared according to
3028
J. Org. Chem. 2021, 86, 3024−3032